How to Treat Gender Dysphoria: Therapy, Hormones & More

Gender dysphoria is treated through a combination of approaches tailored to each person, including psychotherapy, social transition, hormone therapy, and surgery. Not everyone pursues every option, and there is no single correct sequence. The current clinical framework, outlined in the World Professional Association for Transgender Health’s Standards of Care (Version 8), emphasizes individualized care built on the best available evidence and professional consensus.

Mental Health Support and Psychotherapy

Therapy is often the first step, though its role has shifted over the years. Older models treated gender dysphoria itself as something to resolve through talk therapy alone. Current practice is different: therapy helps you explore your gender identity, manage distress, cope with discrimination, and address any co-occurring conditions like depression or anxiety. It is not aimed at changing your identity. A systematic review of gender-affirming interventions found that people who received them showed meaningful improvement in mental health and body image acceptance.¹

Therapy can also be valuable during and after medical transition. Starting hormones or preparing for surgery raises practical and emotional questions. A good therapist familiar with gender-affirming care can help you work through expectations, navigate relationships, and handle the social friction that sometimes accompanies transition. For some people, therapy alone is enough to manage dysphoria, particularly those whose distress is mild or situation-specific.

Social Transition

Social transition means living as your identified gender in daily life: using a different name, different pronouns, different clothing, different restroom. It involves no medical intervention and can happen at any age. For children, research has found that those who socially transitioned during childhood showed no worse mental health outcomes compared to those who transitioned as adults, and in some cases had lower odds of substance use later on.² Among adolescents, the picture is more mixed. A systematic review found that studies consistently reported no difference in mental health outcomes for children who socially transitioned across all comparison groups, while evidence for adolescents was less clear-cut.³

An important nuance: when adolescents who socially transitioned appeared to have worse outcomes, those differences largely disappeared once researchers accounted for school-based harassment related to gender identity.² In other words, the harm seems to come from the bullying, not from the transition itself.

Hormone Therapy

Gender-affirming hormone therapy (GAHT) is one of the most common medical treatments for gender dysphoria. For people seeking feminization, it typically involves estradiol (an estrogen) and an anti-androgen. For people seeking masculinization, it involves testosterone. Both produce gradual physical changes over months to years.

Testosterone’s effects have a well-studied timeline. Changes in mood and sexual interest tend to appear within a few weeks. Fat redistribution, increased muscle mass, and changes in body composition become noticeable at three to four months and stabilize over the first year or two. Effects on red blood cell production peak at around nine to twelve months, and bone density changes are detectable by six months and continue for at least three years.⁴ Testosterone also causes breast tissue changes: androgen-exposed breast tissue develops dense fibrotic tissue and lobular atrophy, with longer exposure producing more pronounced effects.⁵

Feminizing hormone therapy produces breast development, softer skin, reduced body hair growth, and redistribution of fat to a more typically female pattern. These changes unfold over one to three years. Voice changes do not occur with estrogen, which is why many trans women pursue voice training or vocal surgery separately.

Risks and Monitoring

Hormone therapy is generally safe under medical supervision, but it is not without risks. The most significant concern for trans women on estrogen is blood clots. In one of the larger studies, about one percent of trans women experienced a venous clotting event over roughly five years of follow-up, and much of that risk has been linked to older, more thrombogenic forms of estrogen that are no longer standard.⁶ Bone density is another area to watch: about a quarter of trans women in one long-term study had osteoporosis after a decade on hormones, though some of that may reflect the period before estrogen was started.⁶

For trans men on testosterone, cardiovascular events are the primary reported concern. Data from the French pharmacovigilance system found that all reported adverse reactions among trans men taking testosterone were cardiovascular, with pulmonary embolism accounting for half, at a median onset of about three years into treatment. The data also flagged cardiovascular events in trans men under forty, a finding that had not been widely reported previously.⁷ These risks underline the importance of regular bloodwork and clinical follow-up, not a reason to avoid treatment.

Puberty Blockers for Adolescents

For transgender adolescents, puberty blockers (GnRH agonists) can pause the development of secondary sex characteristics, buying time before a young person and their care team decide on further steps. This is among the most debated areas in transgender medicine, though a scoping review of the literature found that puberty blockers can be beneficial, with reductions in mental health difficulties observed during and after their use.⁸

Use of puberty blockers remains relatively uncommon in absolute terms. In a study of U.S. adolescents from 2018 to 2022, the rate was about 21 per 100,000 among those assigned female at birth and about 15 per 100,000 among those assigned male at birth.⁹ Research on youths receiving puberty blockers or hormones found they had substantially lower odds of moderate-to-severe depression and self-harm or suicidal thoughts compared to those who had not yet started treatment, though there was no observed difference in anxiety levels.¹⁰

Surgical Options

Surgery is not something everyone with gender dysphoria pursues, but for those who do, the evidence on satisfaction is consistently strong. Surgical interventions fall into several broad categories.

Chest Surgery

Top surgery for transmasculine individuals (mastectomy with chest contouring) is one of the most commonly sought gender-affirming procedures. In a single-center study, about 90 percent of patients reported being satisfied or partially satisfied with their overall surgical experience. Satisfaction was highest for clothed appearance, with about 89 percent very satisfied. Satisfaction with scars and nipple reconstruction was lower, in the range of 47 to 49 percent very satisfied, and only two patients in the sample expressed regret.¹¹ Nonbinary patients tend to pursue a wider variety of chest procedures than binary trans men, with more opting for breast reduction rather than full mastectomy with nipple grafts.¹²

Genital Surgery

Genital surgery is more complex and comes in several forms. For trans women, vaginoplasty is the primary procedure. A systematic review and meta-analysis found an overall satisfaction rate of about 91 percent and a regret rate of around two percent. Complication rates varied by type: stenosis or stricture occurred in roughly 11 percent of cases, tissue necrosis in about 4 percent, and prolapse in about 3 percent. Vaginal depth achieved depended on technique, averaging around 9 centimeters for penile skin inversion and about 15 centimeters for intestinal approaches.¹³

Phalloplasty, for trans men and some nonbinary individuals, is the most surgically complex gender-affirming procedure. The overall complication rate is high, around 76 percent, driven largely by urethral complications: fistula in about a third of patients and stricture in about a quarter. On the functional side, the vast majority of patients reported tactile sensation and the ability to urinate while standing.¹⁴ Metoidioplasty, a less extensive alternative that uses tissue growth from testosterone, has a lower complication rate but produces a smaller result. The choice between procedures depends on individual priorities around appearance, function, and tolerance for surgical complexity.¹⁵

Facial Feminization Surgery

Facial feminization surgery (FFS) modifies the brow, nose, jaw, chin, and other features to create a more typically feminine facial structure. For many trans women, the face is the most visible source of dysphoria and social misgendering. In a multicenter study, median patient-reported facial feminization outcome scores nearly doubled from about 47 preoperatively to about 81 at six months or more after surgery.¹⁶ A separate study found that FFS independently predicted improved scores on anxiety, depression, social isolation, and overall mental health after controlling for other forms of gender-affirming care.¹⁷

Hair Removal

Laser hair removal and electrolysis are easy to overlook in discussions of transition, but they matter a great deal in practice. For trans women, unwanted facial and body hair can be a persistent source of dysphoria that hormones alone do not fully resolve. Hair removal is also a medical prerequisite before some genital surgeries, since hair-bearing skin used in vaginoplasty or phalloplasty can cause complications if not treated.¹⁸

The mental health impact is measurable. After adjusting for other forms of gender-affirming care, gender-affirming hair removal was associated with roughly a third lower odds of severe psychological distress and about a quarter lower odds of suicidal ideation.¹⁹ This makes it one of the more cost-effective gender-affirming interventions, though insurance coverage varies widely.

Mental Health Outcomes Across Treatments

Across the board, gender-affirming care is associated with better mental health. A review of suicide-related outcomes found that rates of suicidal ideation dropped from about 73 percent before any gender-affirming treatment to about 43 percent after. Rates of suicide attempts fell from about 36 percent before treatment to about 9 percent after.²⁰ A large U.S. study found that having undergone one or more gender-affirming surgeries was associated with roughly 40 percent lower odds of psychological distress, 35 percent lower odds of smoking, and about 44 percent lower odds of suicidal ideation compared to those who had not had surgery.²¹

These are observational findings, not randomized controlled trials, so they cannot prove that the treatments caused the improvements. Randomized trials would be difficult to conduct ethically in this context. But the consistency of the association across different study designs and different types of care is the strongest evidence available.

Satisfaction and Detransition

Regret rates across gender-affirming treatments are low. As mentioned above, regret after vaginoplasty sits at about two percent. For adolescents who received puberty blockers or hormones, a follow-up study found very high satisfaction and low regret. Out of 220 young people surveyed, nine expressed some regret (about four percent), and of those nine, only four had stopped all gender-affirming medical care. The others continued treatment despite mixed feelings, suggesting that regret and discontinuation are not the same thing.²²

Detransition does happen, and the reasons are varied. A survey of 100 people who detransitioned found that 60 percent had become more comfortable identifying as their birth sex, 49 percent had concerns about medical complications, 38 percent came to believe their dysphoria was related to trauma or another mental health condition, and 23 percent cited discrimination as a factor. Over half felt they had not received an adequate evaluation before starting transition, and only about a quarter had told their clinicians they detransitioned.²³ These findings point to the importance of thorough assessment and ongoing follow-up, not as gatekeeping but as genuine clinical support.

Non-Binary and Individualized Approaches

Not everyone with gender dysphoria identifies as the “opposite” binary gender, and treatment guidelines are increasingly adapting to this. Standard hormone therapy protocols are designed for full masculinization or full feminization, but nonbinary individuals often want partial changes. Clinicians can adjust by modifying dose or timeline, a practice sometimes called “microdosing.”²⁴ Research into these regimens, while still in early stages, suggests that microdosing and selective hormone modulators are safe and effective at achieving individualized goals and improving quality of life.²⁵

The surgical side mirrors this flexibility. Nonbinary transmasculine individuals, for example, are more likely to choose breast reduction rather than full mastectomy with nipple grafts, and their satisfaction scores are comparable to those of binary trans men who choose more extensive procedures.¹²

Fertility Preservation

One of the most underappreciated aspects of transition planning is fertility. Both hormone therapy and surgery can affect your ability to have biological children, and current guidelines recommend that all patients be counseled on fertility preservation before starting medical transition. In practice, this counseling often does not happen.²⁶

Uptake of fertility preservation is uneven. In a Swedish cohort, about 76 percent of trans women preserved sperm before transition, but only about 26 percent of trans men preserved oocytes.²⁷ The gap is partly practical: egg freezing is more invasive, expensive, and time-consuming than sperm banking. Among adolescents, there is a consistent gap between receiving fertility counseling and actually going through with preservation. A systematic review found that while counseling rates varied, actual uptake among transgender adolescents and young adults ranged widely and was often very low.²⁸ If future biological parenthood matters to you, the time to ask about options is before starting hormones, not after.

Legal Documents and Administrative Steps

Changing your name and gender marker on identity documents is not a medical treatment, but it has measurable health effects. A study published in The Lancet Public Health found that having all identity documents match your name and gender was associated with a 32 percent reduction in serious psychological distress and a 22 to 25 percent reduction in suicidal ideation and suicide planning, compared to having no concordant documents.²⁹ Even changing documents partially, on just one form of ID, was associated with lower odds of emotional distress from gender-based mistreatment.³⁰

The process varies enormously depending on where you live. Some jurisdictions require a court order, medical documentation, or even proof of surgery. Others allow self-declaration. Regardless of the legal barriers, the clinical data make a strong case that getting your documents in order is not just an administrative chore but something that directly supports your mental health.

Preventive Health and Cancer Screening

Transition does not remove the need for routine health screenings, but it does complicate the picture. If you are a trans man who has not had a hysterectomy, you still need cervical cancer screening. If you are a trans woman who has been on estrogen for years and has developed breast tissue, breast cancer screening becomes relevant. Current recommendations are largely based on which organs are still present, following the same guidelines used for cisgender people, since long-term data on how hormone therapy affects cancer risk are still limited.³¹

The bigger problem is awareness. A survey found that 77 percent of transgender and nonbinary respondents were unaware of breast cancer screening recommendations for their sex assigned at birth or their gender, and 60 percent were unaware of cervical cancer recommendations. Among those over 40, only half had undergone screening mammography.³² Part of this gap is systemic: electronic health records that do not handle gender identity well can lead to inappropriate screening reminders or, more commonly, no reminders at all. Navigating this requires a proactive relationship with a provider who understands which screenings apply to your specific body and hormonal history.³³

The Role of Medical Records

How your identity is recorded in electronic health records affects more than just screening reminders. When records use the wrong name or pronouns, the consequences range from personal distress to avoidance of medical care entirely. One qualitative study found that participants consistently asked for pronouns, name, and gender identity to be used throughout their medical documentation, not just during face-to-face encounters. The frustration of seeing a provider document the correct pronoun in one sentence and then revert to the wrong one in the next was a common theme.³⁴ Accurate documentation is also necessary for public health purposes. Failure to count transgender patients accurately has downstream effects on research, quality improvement, and funding.³⁵

What Neuroimaging Research Shows

A question people sometimes have is whether there is a biological basis for gender dysphoria, and neuroimaging research has found some intriguing patterns. Brain-structure studies suggest that transgender individuals show features that do not neatly match either their birth sex or their identified gender but instead form a distinct pattern. One study found that trans women showed structural differences from both cisgender men and cisgender women in regions like the putamen and insula.³⁶ A broader systematic review confirmed that some brain features in transgender people resemble those of their experienced gender, though the majority still resemble those of their natal sex.³⁷

The honest assessment of this field is that it is still early. Sample sizes are small, measurement tools are crude relative to the complexity of the brain, and conflicting results make it impossible to identify a consistent “signature” of gender identity in brain scans.³⁷ No brain scan can diagnose gender dysphoria, and none is used clinically. But the research does provide evidence against the idea that gender identity is purely a social construct with no biological underpinning.